Vascular Adviser is a new communication hub developed to provide information and educational resources on all areas of Vascular Protection including medical expert insights, disease awareness materials and interactive content. Over time, we hope that Vascular Adviser will be your go-to information hub for all your questions around Vascular Protection.
About Vascular Protection
Vascular disease and its many manifestations, including coronary artery disease (CAD) and peripheral artery disease (PAD), have a major impact on the lives of millions of patients and those around them. Major advances in surgical and medical management strategies have helped healthcare professionals reduce its impact. However, despite these advances, the residual risk of major adverse cardiac events remains high. Research into innovative strategies to address this residual risk is ongoing. Whether it is through the use of different combinations of antithrombotic drugs, reducing lipid levels or other disease mediators, the area of Vascular Protection is exciting and continues to evolve.
Meet the Steering Committee
Vascular Adviser is developed in collaboration with a Steering Committee who are experts in the field of Vascular Protection.
The Steering Committee is dedicated to fostering awareness and understanding about new approaches in the prevention, diagnosis and treatment of vascular diseases.
The role of the Steering Committee
• To provide expert advice on relevant core topics for the Vascular Adviser website
• To provide insights on website structure and features
• To provide overall direction and oversight to ensure the independence and clinical relevance of the Vascular Adviser website
Professor John Eikelboom
MBBS, MSc, FRCPC
Associate Professor of Medicine, McMaster University, Ontario, Canada; Senior Investigator, Population Health Research Institute; Haematologist in the Thrombosis Service, Hamilton General Hospital, Ontario, Canada
Scientific focus: antithrombotic therapy; mechanisms and genetic determinants of antiplatelet drug resistance; mechanisms and prognosis of bleeding
Holds a Heart and Stroke Foundation Career Award, and the Jack Hirsh / Population Health Research Institute Chair in Thrombosis and Atherosclerosis
Editorial board member for Thrombosis and Hemostasis
PROFESSOR JEFFREY I. WEITZ
Professor of Medicine and Biochemistry, McMaster University, Ontario, Canada; Executive Director of the Thrombosis & Atherosclerosis Research Institute, Ontario, Canada
Scientific focus: clinical research on prevention, diagnosis and treatment of clotting disorders; basic and translational research on mechanisms of action of anticoagulants and thrombolytic agents
Received awards from the Royal College of Physicians, Heart and Stroke Foundation, Canadian Cardiovascular Society, American Heart Association, American College of Physicians, and Atherosclerosis, Thrombosis and Vascular Biology Society as well as the Jack Hirsh and Distinguished Innovator Awards from McMaster University; Fellow of the Royal Society of Canada
Member of the American Society for Clinical Investigation, Association of American Physician and the Executive Council of The International Society on Thrombosis and Haemostasis
PROFESSOR E. SEBASTIAN DEBUS
Professor of Surgery and Chairman, Department of Vascular Medicine, University of Hamburg-Eppendorf, Germany
Scientific focus: vascular epidemiology and vascular care; aortic pathologies and peripheral occlusive disease
Co-founder of the German Vascular Registry program
Secretary General of the European Society for Vascular Surgery; Chair of the North German Society for Vascular Medicine; member of the European Society for Vascular Surgery Guidelines Committee; member of the Board of Directors of the European Journal of Vascular and Endovascular Surgery
PROFESSOR GILLES MONTALESCOT
Professor of Cardiology, University of Paris VI, France; Head of the Cardiology Department and Director of Clinical Research at the Institute of Cardiology, Pitié-Salpêtrière Hospital, Paris, France
Scientific focus: interventional cardiology; extensive basic and clinical research on antithrombotic drugs, acute coronary syndrome and stable coronary artery disease
Received the J. Valade Prize from the Fondation de France and the J. Escalle Award from the Académie Nationale de Médecine
Editorial board member of the European Heart Journal; Chairman of ACTION – an independent academic group for clinical research and education
PROFESSOR LISA K. JENNINGS
Clinical Professor, Department of Internal Medicine, University of Tennessee Health Science Center, Memphis, Tennessee, USA
Scientific focus: platelet and coagulation biology; design and pharmacodynamic evaluations of antiplatelet and antithrombin agents in non-clinical and clinical studies; vascular injury response
Awarded research grants by the National Institutes of Health and the American Heart Association
Founder, CirQuest Labs; Former Director of the TN-AR-MS (TAM) Clinical Research Consortium and of the Vascular Biology Center of Excellence at the University of Tennessee Health Science Center
The role of the sponsor (Bayer AG)
The sponsor provides financial support for the website, and reviews content to ensure accuracy of information in compliance with established pharmaceutical codes of practice.